MGTA-145 + Plerixafor in the Mobilization of Hematopoietic Stem Cells for Autologous Transplantation in Multiple Myeloma

NCT04552743 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: MGTA-145
DRUG: Plerixafor

Sponsor

Surbhi Sidana, MD